Clinical Trial Update: Reloading Prasugrel or Clopidogrel on High Platelet Reactivity Before Percutaneous Coronary Intervention [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating reloading of prasugrel or clopidogrel in patients with high platelet reactivity undergoing percutaneous coronary interv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• CLOPIDOGREL (CLOPIDOGREL)
• PRASUGREL (prasugrel)

Snippet

Sponsor: Dong-A University | Conditions: Acute Coronary Syndrome | Phase 3 | Status: COMPLETED